Noggin promotes osteogenesis in human adipose-derived mesenchymal stem cells via FGFR2/Src/Akt and ERK signaling...

Area of Science:

• Cell Biology
• Developmental Biology
• Regenerative Medicine

Background:

• The balance between Noggin and bone morphogenetic proteins (BMPs) is crucial for skeletal development and repair.
• Noggin typically inhibits BMP signaling by binding BMPs extracellularly.
• The possibility of direct Noggin signaling independent of BMP modulation has been proposed.

Purpose of the Study:

• To investigate direct signaling pathways activated by Noggin in stem cells.
• To explore Noggin's role in osteogenic differentiation.
• To identify potential receptors and downstream signaling molecules involved in Noggin's effects.

Main Methods:

• Osteogenic cultures of adipose-derived stem cells (ASCs).
• Analysis of kinase activation (Src/Akt, ERK) and protein stabilization (TAZ).
• Assessment of osteogenic marker expression and mineral deposition.
• Experiments on human bone marrow stem cells, dental pulp stem cells, and osteosarcoma cells.

Main Results:

• Noggin activated fibroblast growth factor receptors (FGFRs), Src/Akt, and ERK kinases in ASCs.
• Noggin stabilized TAZ proteins in the presence of dexamethasone, enhancing osteogenesis.
• Noggin induced osteogenic gene expression in bone marrow stem cells and alkaline phosphatase activity in dental pulp stem cells.
• Noggin specifically activated FGFR2 in osteosarcoma cells.

Conclusions:

• Noggin can directly signal through FGFRs, independent of BMP inhibition.
• Noggin promotes osteogenic differentiation in various human stem cell types.
• The FGFR2/Src/Akt/ERK pathway is involved in Noggin-mediated cell fate modulation.
• Noggin holds potential for applications in bone regenerative therapies.